Bellerophon Therapeutics
| Region | Nordamerika |
| ISIN | US0787713009 |
| Sektor | Medizintechnik, Biotech |
| Website | https://bellerophon.com/ |
Bellerophon is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases.
| Titel | Autor | Datum |
|---|---|---|
|
NO to COVID!
|
rotten.tom | vor ungefähr 8 Monaten |
| Titel | Datum |
|---|---|
| Why Entera Bio, Orphazyme, Bellerophon Are Moving Today | vor ungefähr einem Monat |
| Bellerophon Therapeutics and Entera Bio among healthcare gainers; Second Sight Medical Products and Adial Pharmaceuticals among losers | vor ungefähr einem Monat |
| Bellerophon Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | vor ungefähr 2 Monaten |
| Bellerophon Therapeutics, Inc.: Bellerophon to Present at the Jefferies Virtual Healthcare Conference | vor ungefähr 2 Monaten |
| Bellerophon Therapeutics, Inc. - 8-K, Current Report | vor ungefähr 2 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Bee Vectoring Technologies (1 Artikel) | |
| Bayer (1 Artikel) | |
| Benz Mining (1 Artikel) | |
| Berkeley Energia (1 Artikel) | |
| Alle anzeigen | |